Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 29, 2024
Flap
endonuclease
1
(FEN1)
is
closely
associated
with
tumor
progression
and
proliferation,
making
it
a
promising
biomarker
for
cancer
diagnosis.
However,
developing
sensitive,
reliable,
user-friendly
method
quantitative
FEN1
detection
remains
technically
challenging.
In
this
study,
an
ultrasensitive
biosensor
established
using
target-induced
cleavage-ligation-transcription-activation
cascade
strategy
(LTACas13a)
to
enhance
the
cleavage
ability
of
CRISPR/Cas13a.
The
LTACas13a
has
shown
excellent
performance
in
screening
inhibitors
detecting
endogenous
activity
living
cells,
as
well
clinical
biological
samples
such
human
serum
tissue
samples.
Additionally,
universal
dumbbell
probe
derived
from
FEN1,
multiplex
developed
various
DNA
glycosylases,
including
formamidopyrimidine
glycosylase,
uracil
alkyl
adenine
glycosylase.
This
straightforward
approach
provides
reliable
effective
diagnostic
tool
early-stage
offers
significant
opportunities
biosensing
related
drug
discovery.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 19, 2025
Precise
identification
and
analysis
of
multiple
protein
biomarkers
on
the
surface
breast
cancer
cell-derived
extracellular
vesicles
(BC-EVs)
are
great
significance
for
noninvasive
diagnosis
subtypes,
but
it
remains
a
major
challenge
owing
to
their
high
heterogeneity
low
abundance.
Herein,
we
established
CRISPR-based
homogeneous
electrochemical
strategy
near-zero
background
ultrasensitive
detection
BC-EVs.
To
realize
high-performance
capture
isolation
BC-EVs,
fluidity-enhanced
magnetic
nanoprobes
were
facilely
prepared.
After
capturing
AND
logic
gate-based
catalytic
hairpin
assembly
(CHA)
trans-cleavage
activity
CRISPR-Cas12a
against
signal
triggered
successively,
generating
significant
signal.
Notably,
as-developed
metal-mediated
could
efficiently
decrease
by
separation,
endowing
method
with
signal-to-noise
ratio.
Consequently,
ingeniously
integrating
DNA
CRISPR-CHA
amplification
dual
in
strategy,
precise
BC-EVs
was
successfully
achieved
through
simultaneous
specific
recognition
markers
surface.
More
importantly,
this
approach
effectively
discriminate
subgroups
clinical
serum
samples,
which
may
provide
opportunities
accurate
prognosis
evaluation
manner.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(5), P. 1025 - 1025
Published: Feb. 24, 2025
Mitochondria,
as
vital
organelles,
play
a
central
role
in
subcellular
research
and
biomedical
innovation.
Although
functional
nucleic
acid
(FNA)
nanostructures
have
witnessed
remarkable
progress
across
numerous
biological
applications,
strategies
specifically
tailored
to
target
mitochondria
for
molecular
imaging
therapeutic
interventions
remain
scarce.
This
review
delves
into
the
latest
advancements
leveraging
FNA
mitochondria-specific
cancer
therapy.
Initially,
we
explore
creation
of
FNA-based
biosensors
localized
mitochondria,
enabling
real-time
detection
visualization
critical
molecules
essential
mitochondrial
function.
Subsequently,
examine
developments
aimed
at
mitochondrial-targeted
treatments,
including
modular
nanodevices
precise
delivery
agents
programmable
disrupting
processes.
Emphasis
is
placed
on
elucidating
chemical
principles
underlying
design
mitochondrial-specific
nanotechnology
diverse
uses.
Lastly,
address
unresolved
challenges
outline
prospective
directions,
with
goal
advancing
field
encouraging
sophisticated
tools
both
academic
inquiry
clinical
applications
centered
mitochondria.
Chemical Communications,
Journal Year:
2024,
Volume and Issue:
60(78), P. 10805 - 10821
Published: Jan. 1, 2024
DNAzymes,
a
class
of
single-stranded
catalytic
DNA
with
good
stability,
high
activity,
and
easy
synthesis,
functionalization
modification
properties,
have
garnered
significant
interest
in
the
realm
biosensing
bioimaging.
Their
integration
fluorescent
dyes
or
chemiluminescent
moieties
has
led
to
remarkable
bioimaging
outcomes,
while
DNAzyme-based
biosensors
demonstrated
robust
sensitivity
selectivity
detecting
metal
ions,
nucleic
acids,
proteins,
enzyme
activities,
exosomes,
bacteria
microorganisms.
In
addition,
by
delivering
DNAzymes
into
tumor
cells,
mRNA
therein
can
be
cleaved
regulate
expression
corresponding
which
further
propelled
application
cancer
gene
therapy
synergistic
therapy.
This
paper
reviews
strategies
for
screening
attractive
such
as
SELEX
high-throughput
sequencing,
briefly
describes
amplification
mainly
include
hairpin
assembly
(CHA),
walker,
hybridization
chain
reaction
(HCR),
origami,
CRISPR-Cas12a,
rolling
circle
(RCA),
aptamers.
applications
bioimaging,
biosensing,
are
also
highlighted.
Subsequently,
possible
challenges
these
practical
pointed
out,
future
research
directions
suggested.
Small Methods,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 18, 2024
Abstract
The
CRISPR‐Cas
systems
are
adopted
as
powerful
molecular
tools
for
not
only
genetic
manipulation
but
also
point‐of‐care
diagnostics.
However,
methods
to
enable
diagnostics
of
non‐nucleic‐acid
targets
with
these
still
limited.
Herein,
by
fusing
ligand‐dependent
allosteric
ribozymes
CRISPR‐Cas12a,
a
derived
system
is
created
efficient
quantitative
analysis
in
1–2
h.
On
two
different
small
molecules,
the
system's
generality,
reliability
and
accuracy
demonstrated,
show
that
well
operability
this
can
high‐throughput
detection
molecule
blood
samples.
be
further
converted
rely
on
deoxyribozyme
instead
ribozyme
recognize
transduce
signal
CRISPR‐Cas12a
amplification,
likely
making
it
easier
storage
more
consistent
data
generation
DNA
possess
stability
advantage
over
RNA.
This
(deoxy)ribozyme‐assisted
anticipates
facilitate
bioanalysis
various
scientific
clinical
settings
drive
development
translation.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
A
comprehensive
overview
of
recent
advancements
in
fluorescence
imaging
techniques
for
situ
sensing
various
biomarkers,
emphasizing
the
transformative
potential
artificial
intelligence
shaping
future
bioimaging.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 31, 2024
Abstract
Although
DNAzyme
sensors
have
been
widely
developed
for
imaging
metal
ions,
their
application
in
specific
subcellular
compartments
remains
challenging
due
to
low
spatial
controllability.
Here
we
present
a
locally
activatable,
DNAzyme‐based
sensing
technology
that
enables
compartment‐specific
of
ions
through
ribosomal
RNA
(rRNA)
regulated
signal
amplification.
The
system
leverages
subcellularly
encoded
rRNA
activate
sensors,
and
further
drives
amplification
via
multiple
turnover
cleavage
molecular
beacons,
significantly
enhance
sensitivity
precision
metal‐ion
organelles
(e.g.
mitochondria)
or
membraneless
cytosol).
Furthermore,
demonstrate
the
allows
situ
monitoring
dynamics
mitochondrial
Zn
2+
during
ischemia
drug
intervention.
This
study
expands
toolbox
investigating
role
disease
processes.
Small,
Journal Year:
2024,
Volume and Issue:
20(46)
Published: Aug. 3, 2024
Live
cell
imaging
is
essential
for
obtaining
spatial
and
temporal
insights
into
dynamic
molecular
events
within
heterogeneous
individual
cells,
in
situ
intracellular
networks,
vivo
organisms.
Molecular
tracking
live
cells
also
a
critical
general
requirement
studying
physiological
processes
biology,
cancer,
developmental
neuroscience.
Alongside
this
context,
review
provides
comprehensive
overview
of
recent
research
progress
live-cell
RNAs,
DNAs,
proteins,
small-molecule
metabolites,
as
well
their
applications
diagnosis,
immunodiagnosis,
biochemical
diagnosis.
A
series
advanced
techniques
have
been
introduced
summarized,
including
high-precision
imaging,
high-resolution
low-abundance
multidimensional
multipath
rapid
computationally
driven
methods,
all
which
offer
valuable
disease
prevention,
treatment.
This
article
addresses
the
current
challenges,
potential
solutions,
future
development
prospects
field.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 31, 2024
Although
DNAzyme
sensors
have
been
widely
developed
for
imaging
metal
ions,
their
application
in
specific
subcellular
compartments
remains
challenging
due
to
low
spatial
controllability.
Here
we
present
a
locally
activatable,
DNAzyme-based
sensing
technology
that
enables
compartment-specific
of
ions
through
ribosomal
RNA
(rRNA)
regulated
signal
amplification.
The
system
leverages
subcellularly
encoded
rRNA
activate
sensors,
and
further
drives
amplification
via
multiple
turnover
cleavage
molecular
beacons,
significantly
enhance
sensitivity
precision
metal-ion
organelles
(e.g.
mitochondria)
or
membraneless
cytosol).
Furthermore,
demonstrate
the
allows
situ
monitoring
dynamics
mitochondrial
Zn